Abstract
The dopamine transporter (DAT) provides major regulation of the synaptic levels of dopamine and is a principal target of psychostimulant drugs. Associations between DAT gene polymorphisms and human disorders with possible links to dopaminergic neurotransmission, including attention-deficit/hyperactivity disorder (ADHD) and consequences of cocaine and alcohol administration, have been reported. We now report approximately 60000 bp of genomic sequence containing the entire DAT gene. This sequence was used to amplify each of the 15 DAT gene exons and several introns and analyze these amplification products by single-stranded sequence conformation (SSCP) and/or direct sequencing. These results define silent allelic single nucleotide sequence variants in DAT gene exons 2, 6, 9 and 15. Rare conservative mutations are identified in amino acids encoded by DAT exons 2 and 8. Analyses of the common nucleotide variants and the previously reported VNTR in the non-coding region of exon 15 define the pattern of linkage disequilibrium across the DAT locus. These comprehensive analyses, however, fail to identify any common protein coding DAT sequence variant in more than 150 unrelated individuals free of neuropsychiatric disease, 109 individuals meeting City of Hope criteria for Tourette's syndrome, 64 individuals with DSM-IV diagnoses of ethanol dependence, or 15 individuals with ADHD. These data are consistent with substantial evolutionary conservation of the DAT protein sequence. They suggest that gene variants that alter levels of DAT expression provide the best current candidate mechanism for reported associations between DAT gene markers, ADHD and other more tentatively associated neuropsychiatric disorders.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Uhl GR, Johnson PS . Neurotransmitter transporter: three important gene families for neuronal function J Exp Biol 1994; 196: 229–236
Ritz MC, Lamb RJ, Goldberg SR, Kukor MJ . Cocaine receptors on dopamine transporters are related to self-administration of cocaine Science 1987; 237: 1219–1223
Singer HS, Hahn I-H, Moran T . Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome Ann Neurol 1991; 30: 558–562
Wong DF, Harris JC, Naidu S, Yokoi F, Marenco S, Dannals RF et al. Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo Proc Natl Acad Sci 1996; 93: 5539–5543
Wong DF, Ricaurte G, Grunder G, Rothman R, Naidu S, Singer H et al. Dopamine transporter changes in neuropsychiatric disorders Adv Pharm 1998; 42: 219–223
Uhl GR, Lin Z, Metzger T, Dar D . Dopamine transporter mutants, small molecules, and approaches to cocaine antagonist/dopamine transporter disinhibiter development Met Enz 1998; 296: 456–465
Gainetdinov RR, Fumagalli F, Jones SR, Caron MG . Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter J Neurochem 1997; 69: 1322–1325
Giros B, Jaber M, Jones SR, Wightman RM, Caron MG . Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter Nature 1996; 379: 606–612
Sora I, Wichems C, Takahashi N, Li X-F, Zeng Z, Revay R et al. Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice Proc Natl Acad Sci 1998; 95: 7699–7704
Cook EHJ, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE et al. Association of attention-defect disorder and the dopamine transporter gene Am J Hum Genet 1995; 56: 993–998
Waldman ID, Rowe DC, Abramowitz A, Kozel S, Mohr J, Sherman SL et al. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity Am J Hum Genet 1998; 63: 1767–1776
Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M . Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism Mol Psychiatry 1997; 2: 311–313
Daly G, Hawi Z, Fitzgerald M, Gill M . Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children Mol Psychiatry 1999; 4: 192–196
LaHoste GJ, Swanson JM, Wigal SB, Glabe C, Wigal T, King N et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit-hyperactivity disorder Mol Psychiatry 1996; 1: 121–124
Gelernter J, Kranzler HR, Satel SL, Rao PA . Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia Neuropsychopharmacology 1994; 11: 195–200
Kelsoe J, Sadovnick AD, Kristbjarnarson H, Bergesch P, Mroczkowski-Parker Z, Drennan M et al. Possible locus for bipolar disorder near the dopamine transporter on chromosome 5 Am J Med Genet 1996; 67: 533–540
Schmidt LG, Harms H, Kuhn S, Rommelspacher H, Sander T . Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene Am J Psychiatry 1998; 155: 474–478
Persico AM, Vandenbergh DJ, Smith SS, Uhl GR . Dopamine transporter gene markers are not associated with polysubstance abuse Biol Psychiatry 1993; 34: 265–267
Muramatsu T, Higuchi S . Dopamine transporter gene polymorphism and alcoholism Biochem Biophys Res Com 1995; 211: 28–32
Sander T, Harms H, Podschus J, Finckh U, Nickel B, Rolfs A et al. Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium Biol Psychiatry 1997; 41: 299–304
Daniels J, Williams JD, Asherton P, McGuffin P, Owen M . No association between schizophrenia and polymorphisms within the genes for debrisoquine 4-hydroxylase (CYP2D6) and the dopamine transporter (DAT) Am J Med Gen 1995; 60: 85–87
Persico AM, Wang ZW, Black DW, Andreasen NC, Uhl GR, Crowe RR . Exclusion of close linkage of the dopamine transporter gene with schizophrenia spectrum disorders Am J Psychiatry 1995; 152: 134–136
Comings DE, Wu S, Chui C, Ring RH, Gade R, Ahn C et al. Polygenetic inheritance of Tourette's syndrome, stuttering, attention defect hyperactivity, conduct and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes—DRD2, DBH, and DAT1 Am J Med Genet 1996; 67: 264–288
Higuchi S, Muramatsu T, Arai H, Hayashida M, Sasaki H, Trojanowski JQ . Polymorphisms of dopamine receptor and transporter genes and Parkinson's disease J Neural Transm 1995; 10: 107–113
LeCouteur DG, Leighton PW, McCann SJ, Pond SM . Association of a polymorphism in the dopamine transporter gene with Parkinson's disease Mov Disord 1997; 12: 760–763
Leighton PW, LeCouteur DG, Pang CC, McCann SJ, Chan D, Law LK et al. The dopamine transporter gene and Parkinson's disease in a Chinese population Neurology 1997; 49: 1577–1579
Donovan DM, Vandenbergh DJ, Perry MP, Bird GS, Ingersoll R, Nanthakumar E et al. Human and mouse dopamine transporter genes: conservation of 5′-flanking sequence elements and gene structures Am J Med Genet 1995; 3: 327–335
Vandenbergh DJ, Persico AM, Uhl GR . A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic Taq I RFLPs Mol Brain Res 1992; 15: 161–166
Tyndale RM, Droll KP, Sellers EM . Genetically defined CYP2D6 metabolism provides protection against oral opiate dependence Pharmacogenetics 1997; 7: 375–379
Smith SS, O'Hara BF, Persico AM, Gorelick DA, Newlin DB, Vlahov D et al. Genetic vulnerability to drug abuse: the dopamine D2 receptor TaqI B1 RFLP appears more frequently in polysubstance abusers Arch Gen Psychiatry 1992; 49: 723–727
American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders American Psychiatric Association: Washington DC 1987
Spielman RS, McGinnis RE, Ewens WJ . Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM) Am J Hum Genet 1993; 52: 506–516
Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW et al. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR Genomics 1992; 14: 1104–1106
Bardeesy N, Pelletier J . Mutational detection by single stranded conformational polymorphism Meth Neurosci 1995; 26: 163–183
Thompson M, Comings DE, Feder L, George SR, O'Dowd BF . Mutation screening of the dopamine D1 receptor gene in Tourette's syndrome and alcohol dependent patients Am J Med Genet 1998; 81: 241–244
Kawarai T, Kawakami H, Yamamura Y, Nakamura S . Structure and organization of the gene encoding human dopamine transporter Gene 1997; 195: 11–18
Porzgen P, Bonisch H, Bruss M . Molecular cloning and organization of the coding region of the human norepinephrine transporter gene Biochem Biophys Res Com 1995; 215: 1145–1150
Lesch KP, Balling U, Gross J, Strauss K, Wolozin BL, Murphy DL et al. Organization of the human serotonin transporter gene J Neural Transm 1994; 95: 157–162
Liu QR, Mandiyan S, Nelson H, Nelson N . A family of genes encoding neurotransmitter transporters Proc Natl Acad Sci 1992; 89: 6639–6643
Lander ES, Schork NJ . Genetic dissection of complex traits Science 1994; 265: 2037–2048
Uhl GR, Gold LH, Risch N . Genetic analyses of complex behavioral disorders Proc Natl Acad Sci 1997; 94: 2785–2786
Falconer DS . Introduction to Quantitative Genetics 3rd edn: John Wiley & Sons: New York 1989; p 1
Abrams ES, Murdaugh SE, Lerman LS . Comprehensive detection of single base changes in human genomic DNA using denaturing gradient gel electrophoresis and a GC clamp Genomics 1990; 7: 463–475
Tishkoff SA, Dietzsch E, Speed W, Pakstis AJ, Kidd JR, Cheung K et al. Global patterns of linkage disequilibrium at the CD4 locus and modern human origins Science 1996; 271: 1380–1387
Tiihonen J, Kuikka J, Bergstrom K, Hakola P, Karhu J, Ryynanen O-P et al. Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics Nature Med 1995; 1: 654–657
Cook EJ, Stein MA, Leventhal BL . Family-based association of the dopamine transport gene in attention deficit disorder. In: Blum K, Nobel EP (eds) Handbook of Psychiatric Genetics CRC Press: New York 1997; 297–310
Acknowledgements
The authors would like to thank Dr Carlo Contoreggi, Ms Judith Hess, Ms Brenda Campbell, and Dr Mark Stein for assistance in clinical characterization sample collection from NIDA-IRP subjects. We would also like to thank Shuya Yan and Roxann Ingersoll for expert technical assistance. This work was supported financially by NIDA's Intramural Research Program, and grants from CAMH, the Medical Research Council of Canada, and NIDA.
This article is a ‘United States Government Work’ paper as defined by the US Copyright Act
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vandenbergh, D., Thompson, M., Cook, E. et al. Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations. Mol Psychiatry 5, 283–292 (2000). https://doi.org/10.1038/sj.mp.4000701
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4000701
Keywords
This article is cited by
-
Comprehensive DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia
Journal of Human Genetics (2013)
-
Methylphenidat
Der Nervenarzt (2010)
-
Association study of promoter polymorphisms at the dopamine transporter gene in Attention Deficit Hyperactivity Disorder
BMC Psychiatry (2009)
-
Dopamine transporter (DAT1) VNTR polymorphism in 12 Indian populations
Neurological Sciences (2009)